Dr. Marc Fink’s multifaceted career bridges academia and industry, showcasing expertise in cancer biology and omic sciences. Following his PhD from Mount Sinai and postdoctoral work at Weill Cornell, he held faculty and research positions at LIU Post and Mount Sinai before transitioning to biotech leadership. As VP at Sema4, he led the development of a clinical cancer knowledgebase, and later drove product innovation at Genomenon. With a keen interest in developing more efficient drug discovery tools, Dr. Fink founded Mapping Bio in 2024.

With a background in Statistics, Bioinformatics and Epidemiology, Dror Berel is a consultant with over 20 years of work experience in both academic research, tech and pharma. He solves business problems and scales analytical tools for diverse data domains, leveraging both traditional Machine learning and Causal Inference along with other modern approaches. Among the data domains he specializes in are: genomic biomarker discovery, multi-omic data analysis, and clinical data reporting (CDISC, ADaM, TLGs).